Funding Rounds
IMU Biosciences

IMU Biosciences Series A (2024, $14M)

IMU Biosciences

AI platform to map the human immune system.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $14.64M

Investors